Net Income Summary of Zhejiang Xinguang Pharmaceutical Co., Ltd.

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was 64.35 Million CNY , down -40.86% from previous year.
Zhejiang Xinguang Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q3 was 12.27 Million CNY , up 358.47% from previous quarter.
Zhejiang Xinguang Pharmaceutical Co., Ltd. reported an annual net income of 108.82 Million CNY in 2022, down -4.78% from previous year.
Zhejiang Xinguang Pharmaceutical Co., Ltd. reported an annual net income of 114.28 Million CNY in 2021, up 15.46% from previous year.
Zhejiang Xinguang Pharmaceutical Co., Ltd. reported a quarterly net income of 12.27 Million CNY for 2024 Q3, up 358.47% from previous quarter.
Zhejiang Xinguang Pharmaceutical Co., Ltd. reported a quarterly net income of 2.67 Million CNY for 2024 Q2, down -88.27% from previous quarter.

Annual Net Income Chart of Zhejiang Xinguang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Zhejiang Xinguang Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Net Income	Net Income Growth
2023	64.35 Million CNY	-40.86%
2022	108.82 Million CNY	-4.78%
2021	114.28 Million CNY	15.46%
2020	98.97 Million CNY	5.41%
2019	93.9 Million CNY	6.71%
2018	87.99 Million CNY	-17.11%
2017	106.15 Million CNY	-10.76%
2016	118.95 Million CNY	0.15%
2015	118.78 Million CNY	12.43%
2014	105.65 Million CNY	45.79%
2013	72.46 Million CNY	27.5%
2012	56.83 Million CNY	21.31%
2011	46.85 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q1	22.83 Million CNY	303.6%
2024 Q3	12.27 Million CNY	358.47%
2024 Q2	2.67 Million CNY	-88.27%
2023 Q4	5.65 Million CNY	-71.94%
2023 FY	64.35 Million CNY	-40.86%
2023 Q1	30.44 Million CNY	56.74%
2023 Q2	8.09 Million CNY	-73.41%
2023 Q3	20.16 Million CNY	149.06%
2022 FY	108.82 Million CNY	-4.78%
2022 Q4	19.42 Million CNY	-32.06%
2022 Q3	28.59 Million CNY	58.97%
2022 Q2	17.98 Million CNY	-58.0%
2022 Q1	42.81 Million CNY	62.8%
2021 Q2	18.03 Million CNY	-53.73%
2021 Q4	26.3 Million CNY	-15.05%
2021 Q1	38.98 Million CNY	64.12%
2021 FY	114.28 Million CNY	15.46%
2021 Q3	30.96 Million CNY	71.68%
2020 Q4	23.75 Million CNY	-18.67%
2020 FY	98.97 Million CNY	5.41%
2020 Q2	18.71 Million CNY	-31.45%
2020 Q3	29.2 Million CNY	56.02%
2020 Q1	27.3 Million CNY	10.77%
2019 Q4	24.64 Million CNY	-5.39%
2019 FY	93.9 Million CNY	6.71%
2019 Q3	26.05 Million CNY	145.17%
2019 Q2	10.62 Million CNY	-67.37%
2019 Q1	32.56 Million CNY	49.68%
2018 Q1	32.95 Million CNY	6.13%
2018 Q2	8.66 Million CNY	-73.7%
2018 FY	87.99 Million CNY	-17.11%
2018 Q3	24.61 Million CNY	184.07%
2018 Q4	21.75 Million CNY	-11.61%
2017 Q2	17.87 Million CNY	-46.66%
2017 FY	106.15 Million CNY	-10.76%
2017 Q1	33.51 Million CNY	-2.68%
2017 Q4	31.04 Million CNY	30.87%
2017 Q3	23.72 Million CNY	32.72%
2016 Q2	17.27 Million CNY	-56.58%
2016 FY	118.95 Million CNY	0.15%
2016 Q4	34.43 Million CNY	25.33%
2016 Q3	27.47 Million CNY	59.09%
2016 Q1	39.77 Million CNY	20.84%
2015 Q4	32.91 Million CNY	8.19%
2015 Q1	38.48 Million CNY	0.0%
2015 Q2	16.95 Million CNY	-55.94%
2015 Q3	30.42 Million CNY	79.41%
2015 FY	118.78 Million CNY	12.43%
2014 FY	105.65 Million CNY	45.79%
2013 FY	72.46 Million CNY	27.5%
2012 FY	56.83 Million CNY	21.31%
2011 FY	46.85 Million CNY	0.0%

Peer Net Income Comparison of Zhejiang Xinguang Pharmaceutical Co., Ltd.

Name	Net Income	Net Income Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-1.68 Billion CNY	103.808%
Anhui Fengyuan Pharmaceutical Co., Ltd.	159.28 Million CNY	59.597%
Dong-E-E-Jiao Co.,Ltd.	1.15 Billion CNY	94.408%
Livzon Pharmaceutical Group Inc.	1.95 Billion CNY	96.706%
Hainan Haiyao Co., Ltd.	-106.48 Million CNY	160.435%
Tus-Pharmaceutical Group Co., Ltd.	25.24 Million CNY	-154.91%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.45 Billion CNY	95.592%
Changchun High-Tech Industries (Group) Inc.	4.53 Billion CNY	98.58%
Apeloa Pharmaceutical Co.,Ltd	1.05 Billion CNY	93.902%
PKU HealthCare Corp.,Ltd.	44.35 Million CNY	-45.089%
Chengdu Huasun Technology Group Inc., Ltd.	27.65 Million CNY	-132.674%
Dezhan Healthcare Company Limited	83.31 Million CNY	22.755%
Jinling Pharmaceutical Company Limited	99.65 Million CNY	35.419%
Jiuzhitang Co., Ltd.	297.41 Million CNY	78.361%
Huapont Life Sciences Co., Ltd.	302.12 Million CNY	78.699%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	618.89 Million CNY	89.601%
Shandong Wohua Pharmaceutical Co., Ltd.	58.76 Million CNY	-9.511%
Hengkang Medical Group Co., Ltd.	30.77 Million CNY	-109.109%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	263.27 Million CNY	75.555%
Qianjiang Yongan Pharmaceutical Co., Ltd.	-12.31 Million CNY	622.69%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	-783.25 Million CNY	108.217%
Jinhe Biotechnology CO., LTD.	86.45 Million CNY	25.562%
Teyi Pharmaceutical Group Co.,Ltd	253.17 Million CNY	74.58%
Kunming Longjin Pharmaceutical Co., Ltd.	-70.94 Million CNY	190.718%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-148.52 Million CNY	143.329%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.04 Billion CNY	93.84%
Anhui Huangshan Capsule Co., Ltd.	64.86 Million CNY	0.782%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	110.43 Million CNY	41.723%
Zhuhai Rundu Pharmaceutical Co., Ltd.	66.89 Million CNY	3.8%
Huaren Pharmaceutical Co., Ltd.	188.06 Million CNY	65.779%
Tianjin Ringpu Bio-Technology Co.,Ltd.	452.94 Million CNY	85.791%
Shanxi Zhendong Pharmaceutical Co.,Ltd	-43.98 Million CNY	246.318%
Fuan Pharmaceutical (Group) Co., Ltd.	231.86 Million CNY	72.244%
Hybio Pharmaceutical Co., Ltd.	-513.87 Million CNY	112.524%
Baotou Dongbao Bio-Tech Co.,Ltd	119.88 Million CNY	46.318%
Hunan Er-Kang Pharmaceutical Co., Ltd	-195.32 Million CNY	132.949%
Changjiang Pharmaceutical Group Co., Ltd.	-605.65 Million CNY	110.626%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	192.34 Million CNY	66.542%
Fujian Cosunter Pharmaceutical Co., Ltd.	-348.58 Million CNY	118.462%
Beijing Science Sun Pharmaceutical Co., Ltd.	102.91 Million CNY	37.468%
Hainan Poly Pharm. Co., Ltd	85.92 Million CNY	25.1%
Jiangxi Synergy Pharmaceutical Co., Ltd.	105.98 Million CNY	39.277%
Wuhan Hiteck Biological Pharma Co.,Ltd	-120.82 Million CNY	153.265%
Shandong Xinhua Pharmaceutical Company Limited	496.51 Million CNY	87.038%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	27.35 Million CNY	-135.227%
PharmaBlock Sciences (Nanjing), Inc.	197.36 Million CNY	67.391%
Jinghua Pharmaceutical Group Co., Ltd.	247.69 Million CNY	74.018%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-420.05 Million CNY	115.321%
Betta Pharmaceuticals Co., Ltd.	348.03 Million CNY	81.508%
Tibet AIM Pharm. Inc.	15.38 Million CNY	-318.266%
Shenzhen Kangtai Biological Products Co., Ltd.	861.3 Million CNY	92.528%
Shandong Shanda Wit Science and Technology Co., Ltd.	585.26 Million CNY	89.004%
Pacific Shuanglin Bio-pharmacy Co., LTD	612.11 Million CNY	89.486%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	138.37 Million CNY	53.49%
Xiamen Kingdomway Group Company	276.71 Million CNY	76.742%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	25.19 Million CNY	-155.428%
Walvax Biotechnology Co., Ltd.	419.39 Million CNY	84.655%
Sunflower Pharmaceutical Group Co.,Ltd	1.11 Billion CNY	94.249%
Harbin Gloria Pharmaceuticals Co., Ltd	120.33 Million CNY	46.519%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	2.85 Billion CNY	97.744%
Hunan Hansen Pharmaceutical Co., Ltd.	205.01 Million CNY	68.609%
Changzhou Qianhong Biopharma CO.,LTD	181.86 Million CNY	64.612%
Shenzhen Weiguang Biological Products Co., Ltd.	218.65 Million CNY	70.567%
Honz Pharmaceutical Co., Ltd.	11.52 Million CNY	-458.172%
Northeast Pharmaceutical Group Co., Ltd.	358.45 Million CNY	82.046%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	43.93 Million CNY	-46.485%
Guizhou Xinbang Pharmaceutical Co., Ltd.	287.23 Million CNY	77.594%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	361.82 Million CNY	82.214%
Zhejiang Yatai Pharmaceutical Co., Ltd.	-11.87 Million CNY	641.86%
Zhejiang NHU Company Ltd.	2.7 Billion CNY	97.62%
ApicHope Pharmaceutical Co., Ltd	184.61 Million CNY	65.14%
Shanghai Kaibao Pharmaceutical CO.,Ltd	327.87 Million CNY	80.371%
Beijing SL Pharmaceutical Co., Ltd.	416.69 Million CNY	84.555%
Yunnan Baiyao Group Co.,Ltd	4.09 Billion CNY	98.428%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	61.64 Million CNY	-4.394%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	161.53 Million CNY	60.159%
Guangdong Lifestrong Pharmacy Co., Ltd.	33.5 Million CNY	-92.099%
Huadong Medicine Co., Ltd	2.83 Billion CNY	97.733%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.03 Billion CNY	93.793%
Harbin Medisan Pharmaceutical Co., Ltd.	73.66 Million CNY	12.634%
LanZhou Foci Pharmaceutical Co.,Ltd.	67.18 Million CNY	4.217%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	506.63 Million CNY	87.297%
Beijing Beilu Pharmaceutical Co., Ltd	-71.75 Million CNY	189.687%
Nanjing Hicin Pharmaceutical Co., Ltd.	36.31 Million CNY	-77.215%
Renhe Pharmacy Co., Ltd.	567.25 Million CNY	88.655%
Chongqing Pharscin Pharmaceutical Co., Ltd.	32.69 Million CNY	-96.814%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	563.08 Million CNY	88.571%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-661.13 Million CNY	109.734%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-414.51 Million CNY	115.526%

Global Stocks Search

Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ)

Net Income Summary of Zhejiang Xinguang Pharmaceutical Co., Ltd.

Annual Net Income Chart of Zhejiang Xinguang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Net Income of Zhejiang Xinguang Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Net Income Comparison of Zhejiang Xinguang Pharmaceutical Co., Ltd.